NPI Details
Kamran Tasharofi, M.D. is an internal medicine in Garwood, NJ with 26 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. Kamran Tasharofi, M.D. NPI is 1174595466. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
The provider's business location address is:
300 SOUTH AVE
GARWOOD, NJ
ZIP 07027-312
Phone: (908) 232-2273
Fax: (908) 232-1439
The NPI 1174595466 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
- Insertion of needle into vein for collection of blood sample (HCPCS:36415)
- Management using the results of remote vital sign monitoring per calendar month, first 20 minutes (HCPCS:99457)
- Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
- Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
- Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days (HCPCS:99454)
- Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
- Injection of drug or substance under skin or into muscle (HCPCS:96372)
- Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
- Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
- Annual depression screening, 15 minutes (HCPCS:G0444)
- Follow-up nursing facility visit per day, typically 25 minutes (HCPCS:99309)
- Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
- Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
- Administration of influenza virus vaccine (HCPCS:G0008)
- Follow-up nursing facility visit per day, typically 15 minutes (HCPCS:99308)
- Influenza vaccine split virus, preservative free (HCPCS:90662)
- Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
- Established patient custodial care facility, group care, or assisted living visit, typically 1 hour (HCPCS:99337)
- Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
- Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes (HCPCS:99458)
- New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
- Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
- Hospital discharge day management, more than 30 minutes (HCPCS:99239)
- Automated urinalysis test (HCPCS:81003)
- Initial nursing facility visit per day, typically 45 minutes (HCPCS:99306)
- Administration of pneumococcal vaccine (HCPCS:G0009)
- Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
- Established patient home visit, typically 1 hour (HCPCS:99350)
- Administration and interpretation of patient-focused health risk assessment (HCPCS:96160)
- Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) (HCPCS:87811)
- Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
- Inhalation treatment for airway obstruction or sputum production (HCPCS:94640)
- Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
- Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg (HCPCS:J7613)
- Follow-up nursing facility visit per day, typically 35 minutes (HCPCS:99310)
- Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
- New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
- Aspiration and/or injection of fluid from large joint (HCPCS:20610)
- Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)
- X-ray of chest, 2 views (HCPCS:71046)
- Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment (HCPCS:G0402)
- Pneumococcal vaccine, 13-valent (HCPCS:90670)
- Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
- Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram (HCPCS:J7644)
- Ultrasound of both sides of head and neck blood flow (HCPCS:93880)
- Transitional care management services for problem of high complexity (HCPCS:99496)
- Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes (HCPCS:99335)
- Screening 3d breast mammography (HCPCS:77063)
- Screening mammography (HCPCS:77067)
- Pneumococcal vaccine, 23-valent (HCPCS:90732)
- Removal of impacted ear wax (HCPCS:69210)
- Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) (HCPCS:87880)
- Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory (HCPCS:Q0091)
- Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and (HCPCS:G0180)
- Influenza vaccine, quadrivalent derived from recombinant dna (HCPCS:90682)
- Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use (HCPCS:90677)
- Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts (HCPCS:93978)
- Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
- Nursing facility discharge management, more than 30 minutes (HCPCS:99316)
- Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report (HCPCS:G0403)
- Varicose vein removal (HCPCS:NAN08)
The enumeration date for this NPI number is 2/2/2006 and was last updated on 7/23/2025.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 207R00000X | Internal Medicine | | 71422 | ARIZONA | No |
| 2 | 207R00000X | Internal Medicine | | 25MA076165 | NEW JERSEY | Yes |
Other Identifiers
The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.
| No. |
Other Provider Identifier |
Other Provider Identifier Type |
Other Provider Identifier State |
Other Provider Identifier Issuer |
| 1 | 0031208 | MEDICAID | NEW JERSEY | |
